DermTech, Inc.
DMTKQ · OTC
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
|---|---|---|---|---|
| Revenue | $4 | $4 | $4 | $4 |
| % Growth | -2% | 0.2% | -1.6% | – |
| Cost of Goods Sold | $3 | $3 | $4 | $4 |
| Gross Profit | $1 | $0 | $0 | $0 |
| % Margin | 18.5% | 11.2% | 4.4% | 0.2% |
| R&D Expenses | $3 | $3 | $4 | $4 |
| G&A Expenses | $10 | $8 | $8 | $15 |
| SG&A Expenses | $18 | $17 | $16 | $28 |
| Sales & Mktg Exp. | $8 | $8 | $8 | $13 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $21 | $20 | $20 | $32 |
| Operating Income | -$21 | -$20 | -$20 | -$32 |
| % Margin | -533.4% | -503.4% | -506% | -807.3% |
| Other Income/Exp. Net | $0 | $1 | $1 | $1 |
| Pre-Tax Income | -$20 | -$19 | -$19 | -$31 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$20 | -$19 | -$19 | -$31 |
| % Margin | -520.4% | -486.5% | -489.5% | -788% |
| EPS | -0.58 | -0.56 | -0.57 | -0.99 |
| % Growth | -3.6% | 1.8% | 42.4% | – |
| EPS Diluted | -0.58 | -0.56 | -0.57 | -0.99 |
| Weighted Avg Shares Out | 35 | 34 | 34 | 32 |
| Weighted Avg Shares Out Dil | 35 | 34 | 34 | 32 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $1 | $1 | $1 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $1 | $1 | $1 | $1 |
| EBITDA | -$19 | -$18 | -$18 | -$31 |
| % Margin | -496.8% | -469.1% | -471.6% | -770.2% |